Boston Scientific CorporationBSXNYSE
Loading
Price to Sales HistoryFair Value
Percentile Rank93
3Y CAGR+10.4%
5Y CAGR+6.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+10.4%/yr
vs +1.2%/yr prior
5Y CAGR
+6.5%/yr
Recent acceleration
Acceleration
+9.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.03 | -10.4% |
| 2024 | 7.85 | +33.0% |
| 2023 | 5.90 | +13.0% |
| 2022 | 5.22 | +2.7% |
| 2021 | 5.08 | -1.1% |
| 2020 | 5.14 | -12.3% |
| 2019 | 5.86 | +18.0% |
| 2018 | 4.97 | +32.4% |
| 2017 | 3.75 | +7.2% |
| 2016 | 3.50 | - |